A Study Comparing KB803 and Matched Placebo in Patients With Dystrophic Epidermolysis Bullosa

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(5 sites)

United States

Mission Dermatology Center, Rancho Santa Margarita, California

Skin Research Institute, Coral Gables, Florida

UMass Memorial Medical Center, Worcester, Massachusetts

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Texas Dermatology and Laser Specialists, San Antonio, Texas